$ASMB
Assembly Biosciences Inc Stock $asmb

$asmb Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000114420415063729 Filed on November 09, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.950M	$2.490M	$3.310M
YoY Change	-10.88%	-66.26%	-73.15%
% of Gross Profit
Research & Development	$5.230M	$4.630M	$2.980M
YoY Change	75.5%	26.09%	-2228.57%
% of Gross Profit
Depreciation & Amortization	$10.00K	$18.00K	$10.00K
YoY Change	0.0%	1023.6%	0.0%
% of Gross Profit
Operating Expenses	$8.180M	$4.630M	$6.280M
YoY Change	30.25%	26.09%	-48.48%
Operating Profit		-$7.122M
YoY Change		-35.58%
Interest Expense	$430.0K	$500.0K	$60.00K
YoY Change	616.67%	1150.0%	20.0%
% of Operating Profit
Other Income/Expense, Net		$504.3K
YoY Change		1333.38%
Pretax Income	-$7.750M	-$6.620M	-$6.230M
YoY Change	24.4%	-39.93%	-48.68%
Income Tax
% Of Pretax Income
Net Earnings	-$7.748M	-$6.618M	-$6.230M
YoY Change	24.37%	-39.95%	-48.68%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$449.5K	-$384.7K	-$590.5K
COMMON SHARES
Basic Shares Outstanding	17.23M shares	17.19M shares	10.65M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$67.70M	$65.80M	$29.10M
YoY Change	132.65%	267.6%	7.38%
Cash & Equivalents	$27.11M	$36.40M	$29.09M
Short-Term Investments	$40.60M	$29.40M
Other Short-Term Assets	$704.3K	$705.3K	$125.3K
YoY Change	462.15%	379.21%	96.76%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$68.37M	$66.50M	$29.22M
YoY Change	134.01%	267.83%	7.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$148.6K	$156.5K	$156.4K
YoY Change	-5.01%	359.11%	2102.77%
Goodwill		$12.64M	$12.74M
YoY Change		0.0%
Intangibles		$29.00M	$29.00M
YoY Change		-3.77%
Long-Term Investments	$23.60M	$31.40M	$100.0K
YoY Change	23500.0%
Other Assets
YoY Change
Total Long-Term Assets	$65.38M	$73.15M	$42.01M
YoY Change	55.62%	72.88%	591406.56%
TOTAL ASSETS
Total Short-Term Assets	$68.37M	$66.50M	$29.22M
Total Long-Term Assets	$65.38M	$73.15M	$42.01M
Total Assets	$133.7M	$139.7M	$71.23M
YoY Change	87.78%	131.24%	162.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.400M	$1.500M	$900.0K
YoY Change	55.56%	50.0%	-65.58%
Accrued Expenses	$2.039M	$1.187M	$146.4K
YoY Change	1292.71%		524.79%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.403M	$2.652M	$1.054M
YoY Change	222.85%	152.77%	-60.05%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$11.60M	$11.60M	$11.60M
YoY Change	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.403M	$2.652M	$1.054M
Total Long-Term Liabilities	$11.60M	$11.60M	$11.60M
Total Liabilities	$15.00M	$14.25M	$12.65M
YoY Change	18.56%	8.03%	379.67%
SHAREHOLDERS EQUITY
Retained Earnings		-$156.2M	-$135.5M
YoY Change		20.83%	21.29%
Common Stock	$17.23K	$17.23K	$10.67K
YoY Change	61.41%		157.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$118.7M	$125.4M	$58.57M
YoY Change
Total Liabilities & Shareholders Equity	$133.7M	$139.7M	$71.23M
YoY Change	87.71%	131.24%	162.51%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q4
OPERATING ACTIVITIES
Net Income	-$7.748M	-$6.618M	-$6.230M
YoY Change	24.37%	-39.95%	-48.68%
Depreciation, Depletion And Amortization	$10.00K	$18.00K	$10.00K
YoY Change	0.0%	1023.6%	0.0%
Cash From Operating Activities	-$5.460M	-$5.180M	-$3.590M
YoY Change	52.09%	33.85%	-33.52%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	$0.00	-$130.0K
YoY Change	-92.31%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$3.830M	-$12.19M	-$80.00K
YoY Change	4687.5%	-2490.2%
Cash From Investing Activities	-$3.840M	-$12.19M	-$210.0K
YoY Change	1728.57%	-2587.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$15.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	260.0K	14.97M
YoY Change	-100.0%		6408.7%
NET CHANGE
Cash From Operating Activities	-5.460M	-5.180M	-3.590M
Cash From Investing Activities	-3.840M	-12.19M	-210.0K
Cash From Financing Activities	0.000	260.0K	14.97M
Net Change In Cash	-9.300M	-17.11M	11.17M
YoY Change	-183.26%	406.21%	-316.05%
FREE CASH FLOW
Cash From Operating Activities	-$5.460M	-$5.180M	-$3.590M
Capital Expenditures	-$10.00K	$0.00	-$130.0K
Free Cash Flow	-$5.450M	-$5.180M	-$3.460M
YoY Change	57.51%	34.55%	-35.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29000000	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	29396382	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2015Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	31186107	USD
CY2014Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	USD
CY2015Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	73150852	USD
CY2014Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	42008796	USD
CY2015Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11600000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	125402447	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	58571172	USD
CY2015Q3	us-gaap	Goodwill Goodwill	12638136	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13132336	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	21479349	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2651569	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	705295	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	29216397	USD
CY2014Q4	us-gaap	Goodwill Goodwill	12737350	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	125284	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29000000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	66503164	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156483	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-156217629	USD
CY2014Q4	us-gaap	Assets Assets	71225193	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1054021	USD
CY2015Q3	us-gaap	Security Deposit SecurityDeposit	170126	USD
CY2015Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1464339	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1187230	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135512072	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71225193	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	11600000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	281990728	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	17226	USD
CY2014Q4	us-gaap	Security Deposit SecurityDeposit	115005	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	194072572	USD
CY2015Q3	us-gaap	Liabilities Liabilities	14251569	USD
CY2014Q4	us-gaap	Liabilities Liabilities	12654021	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	11600000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	139654016	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	10672	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	146420	USD
CY2014Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	907601	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156441	USD
CY2015Q3	us-gaap	Assets Assets	139654016	USD
	us-gaap	Interest Income Other InterestIncomeOther	772183	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	773792	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20705557	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8347013	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.36
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	15189395	shares
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11600000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-387878	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4630148	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3671983	USD
CY2015Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	7122226	USD
CY2014Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11055440	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7122226	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11055440	USD
CY2015Q3	us-gaap	Interest Income Other InterestIncomeOther	502684	USD
CY2014Q3	us-gaap	Interest Income Other InterestIncomeOther	35182	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	504293	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	35182	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-6617933	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-11020258	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2492078	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.33
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17205863	shares
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8277355	shares
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7741317	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	17671735	USD
	us-gaap	Interest Income Other InterestIncomeOther	112287	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	112287	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17559448	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9930418	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.02
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5814316	shares
CY2015Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-253659	USD
CY2014Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-387878	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6871592	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11020258	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21093435	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17559448	USD
	us-gaap	Depreciation Depreciation	47949	USD
	us-gaap	Depreciation Depreciation	3894	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6355453	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8002033	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13242134	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11380582	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47991	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20526	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61016749	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	488837	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81569257	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1763104	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7310374	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-9128641	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27061268	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17932627	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	556738	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2481612	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1140024	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	18464	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	580011	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	43360	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	440	USD
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-55121	USD
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	0	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	63668536	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax	-387878	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax	0	USD
	asmb	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	88	USD
	asmb	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	81014989	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1763104	USD
	asmb	Accrued Offering Cost Related To Issuance Of Common Stock AccruedOfferingCostRelatedToIssuanceOfCommonStock	0	USD
	asmb	Stock Issued During Period Value Common Stock Issued StockIssuedDuringPeriodValueCommonStockIssued	81014989	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	554268	USD
	asmb	Adjustments To Additional Paid In Capital Cashless Exercise Of Warrants AdjustmentsToAdditionalPaidInCapitalCashlessExerciseOfWarrants	0	USD
CY2014Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.04
CY2014Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1959000	shares
CY2014Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15000000	USD
CY2014Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	23540	USD
CY2014Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	10350	USD
CY2014Q3	asmb	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill	12638136	USD
CY2014Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	42197995	USD
CY2014Q3	asmb	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses	774899	USD
CY2014Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent	11600000	USD
CY2014Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	12374899	USD
CY2014Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	29823096	USD
CY2014Q3	us-gaap	Security Deposit SecurityDeposit	16606	USD
CY2014Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	29000000	USD
CY2014Q3	asmb	Noncash Or Part Noncash Acquisition Share Exchange Business Combination NoncashOrPartNoncashAcquisitionShareExchangeBusinessCombination	29064148	USD
CY2014Q3	asmb	Noncash Or Part Noncash Acquisition Fair Value Of Vested Options And Restricted Stock NoncashOrPartNoncashAcquisitionFairValueOfVestedOptionsAndRestrictedStock	758948	USD
CY2014Q3	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	4008848	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	621651	shares
CY2015Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	60970367	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	-387878	USD
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	60582489	USD
CY2015Q3	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	0	USD
CY2015Q3	asmb	Business Acquisition Intangible Expected Tax Deductible Amount BusinessAcquisitionIntangibleExpectedTaxDeductibleAmount	0	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	99214	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	254673	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	206682	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	98190	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50241	USD
CY2015Q3	us-gaap	Depreciation Depreciation	17552	USD
CY2014Q3	us-gaap	Depreciation Depreciation	1602	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	886211	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	0	USD
CY2015Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	234908	USD
CY2014Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	0	USD
CY2015Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	66111	USD
	asmb	Noncash Or Part Noncash Acquisition Other Current Assets NoncashOrPartNoncashAcquisitionOtherCurrentAssets	-23540	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	146420	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3301333	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3471152	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	94147	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6355453	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8002033	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	377500	shares
	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	293945	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2023713	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.69
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.26
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.32
	asmb	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue	0	USD
	asmb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodTotalIntrinsicValue	0	USD
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	6638359	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3237851	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3244984	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.26
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.13
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5187924	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9824224	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	76422	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.25
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	91942	USD
CY2015Q3	asmb	Future Stock Based Compensation Expense Year Two FutureStockBasedCompensationExpenseYearTwo	2767874	USD
CY2015Q3	asmb	Future Stock Based Compensation Expense Year Three FutureStockBasedCompensationExpenseYearThree	695674	USD
CY2015Q3	asmb	Future Stock Based Compensation Expense Total FutureStockBasedCompensationExpenseTotal	5036792	USD
CY2015Q3	asmb	Future Stock Based Compensation Expense Remainder Of Fiscal Year FutureStockBasedCompensationExpenseRemainderOfFiscalYear	1295040	USD
CY2015Q3	asmb	Future Stock Based Compensation Expense Year Four FutureStockBasedCompensationExpenseYearFour	231236	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	ASSEMBLY BIOSCIENCES, INC.
	dei	Entity Central Index Key EntityCentralIndexKey	0001426800
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	ASMB
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17225662	shares
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17225662	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10672059	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17225662	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10672059	shares
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	679447	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-509363	USD
	asmb	Noncash Or Part Noncash Acquisition Other Current Assets NoncashOrPartNoncashAcquisitionOtherCurrentAssets	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	-10350	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	29000000	USD
	asmb	Noncash Or Part Noncash Acquisition Other Current Goodwill NoncashOrPartNoncashAcquisitionOtherCurrentGoodwill	0	USD
	asmb	Noncash Or Part Noncash Acquisition Other Current Goodwill NoncashOrPartNoncashAcquisitionOtherCurrentGoodwill	-12638136	USD
	asmb	Noncash Or Part Non Cash Security Deposit NoncashOrPartNonCashSecurityDeposit	0	USD
	asmb	Noncash Or Part Non Cash Security Deposit NoncashOrPartNonCashSecurityDeposit	-16606	USD
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	774899	USD
	asmb	Noncash Or Part Noncash Acquisition Share Exchange Business Combination NoncashOrPartNoncashAcquisitionShareExchangeBusinessCombination	29064148	USD
	asmb	Noncash Or Part Noncash Acquisition Fair Value Of Vested Options And Restricted Stock NoncashOrPartNoncashAcquisitionFairValueOfVestedOptionsAndRestrictedStock	0	USD
	asmb	Noncash Or Part Noncash Acquisition Deferred Tax Liability NoncashOrPartNoncashAcquisitionDeferredTaxLiability	0	USD
	asmb	Noncash Or Part Noncash Acquisition Deferred Tax Liability NoncashOrPartNoncashAcquisitionDeferredTaxLiability	11600000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	509363	USD
	asmb	Redemption Of Marketable Securities RedemptionOfMarketableSecurities	-2699778	USD
	asmb	Redemption Of Marketable Securities RedemptionOfMarketableSecurities	0	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Use of Estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Significant estimates inherent in the preparation of the accompanying financial statements include recoverability and useful lives (indefinite or finite) of intangible assets, assessment of impairment of goodwill, the valuation allowance related to the Company’s deferred tax assets, and the fair value of stock options and warrants granted to employees, consultants, directors, investors, licensors, placement agents and underwriters.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	99000	USD
CY2015Q3	us-gaap	Area Of Land AreaOfLand	6286	acre
CY2015Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	70414	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	171225	USD
	asmb	Operating Lease Expiration Month And Year OperatingLeaseExpirationMonthAndYear	2016-08
	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	122017	USD
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	USD
	asmb	Noncash Or Part Noncash Acquisition Share Exchange Business Combination NoncashOrPartNoncashAcquisitionShareExchangeBusinessCombination		USD
CY2014Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	509363	USD
CY2015Q3	asmb	Futurestockbasedcompensationexpenseyearfive Futurestockbasedcompensationexpenseyearfive	46968	USD
	asmb	Description For Area Of Land DescriptionForAreaOfLand	(subject to increase up to an aggregate of approximately 10,794 square feet)
	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	10130	USD
CY2015Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	88293	shares
CY2015Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	1609	USD
CY2014Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	1609	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD

Files In Submission

Name	View Source	Status
0001144204-15-063729-index-headers.html	Edgar Link	pending
0001144204-15-063729-index.html	Edgar Link	pending
0001144204-15-063729.txt	Edgar Link	pending
0001144204-15-063729-xbrl.zip	Edgar Link	pending
asmb-20150930.xml	Edgar Link	completed
asmb-20150930.xsd	Edgar Link	pending
asmb-20150930_cal.xml	Edgar Link	unprocessable
asmb-20150930_def.xml	Edgar Link	unprocessable
asmb-20150930_lab.xml	Edgar Link	unprocessable
asmb-20150930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v423200_10q.htm	Edgar Link	pending
v423200_ex31-1.htm	Edgar Link	pending
v423200_ex31-2.htm	Edgar Link	pending
v423200_ex32-1.htm	Edgar Link	pending
v423200_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ASMB
Assembly Biosciences Inc Stock $asmb

2015 Q4 Form 10-Q Financial Statement

#000114420415063729 Filed on November 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASMB Assembly Biosciences Inc Stock $asmb

2015 Q4 Form 10-Q Financial Statement

#000114420415063729 Filed on November 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASMB
Assembly Biosciences Inc Stock $asmb